few more so than Eisai, which is developing a package of products and services in Japan for people living with dementia. Its latest venture is an alliance with Tokyo-based Lifenet Insurance Co ...

Eisai's digital tool to allow self-assessment of cognitive performance – NouKNOW – will be used in a Japanese project aimed ... be deployed in Bunkyo City, Tokyo in a dementia monitoring ...

TOKYO -- Japanese drugmaker Eisai's share price is hovering around a 10-year low of 4,300 yen, weighed down by poor U.S. sales of its much-touted Alzheimer's treatment Leqembi and the company's ...

Lecanemab, the first medication designed to remove amyloid beta, a protein believed to cause Alzheimer’s, was developed by Japan’s Eisai Co. and its U.S. partner, Biogen Inc. “We believe ...

TOKYO, Mar 5, 2025 - (JCN Newswire) - Sato Pharmaceutical Co., Ltd. and Eisai Co., Ltd. announced today that they will conclude their co-promotion based on the co-promotion agreement in Japan ...

TOKYO, Mar 25, 2025 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been selected by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE) as a Nadeshiko ...

This award recognized LEQEMBI as “a world-first treatment for early AD developed in Japan which selectively binds to and clears neurotoxic substances (abnormal proteins), thereby reducing the rate of ...

January 24, 2025 Merck, Eisai's combination drug fails in late-stage trial for esophageal cancer Merck and Japan-based Eisai said on Friday a combination of their therapies failed to extend the ...

Japan’s official cherry blossom spotters on Monday confirmed the first blooming of the country’s favorite flower, declaring ...

A medication that could help treat early stages of Alzheimer's disease is on track to be approved for manufacturing and sales in Japan after ... panel on Aug. 21. Eisai Co. and U.S. partner ...

Investing.com – Japan equities were ... At the close in Tokyo, the Nikkei 225 added 0.04%. The biggest gainers of the session on the Nikkei 225 were Eisai Co., Ltd. (TYO:4523), which rose ...